Wordt geladen...
LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
The constitutive activation of signal transducer and activator of transcription 3 (STAT3) is frequently detected in clinical incidences of hepatocellular carcinoma (HCC) but not in normal human hepatocytes. STAT3 signaling plays pivotal roles in angiogenesis, survival, metastasis, and growth of HCC....
Bewaard in:
| Gepubliceerd in: | Oncotarget |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4484430/ https://ncbi.nlm.nih.gov/pubmed/25883212 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|